Dapson in the Treatment of Pyoderma Gangrenosum: a Narrative Review

Pyoderma gangrenosum is a rare but highly debilitating dermatologic condition frequently associated with systemic disorders such as inflammatory bowel disease and rheumatoid arthritis. The clinical management of pyoderma gangrenosum is particularly challenging due to the absence of standardized diag...

Full description

Saved in:
Bibliographic Details
Main Authors: Paweł Głuszak, Jacek Beutler, Nina Kurkowska, Adriana Polańska, Ryszard Żaba, Aleksandra Dańczak-Pazdrowska
Format: Article
Language:English
Published: Termedia Publishing House 2025-02-01
Series:Przegląd Dermatologiczny
Subjects:
Online Access:https://www.termedia.pl/Dapson-in-the-Treatment-of-Pyoderma-Gangrenosum-a-Narrative-Review,56,55784,1,1.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850032503025303552
author Paweł Głuszak
Jacek Beutler
Nina Kurkowska
Adriana Polańska
Ryszard Żaba
Aleksandra Dańczak-Pazdrowska
author_facet Paweł Głuszak
Jacek Beutler
Nina Kurkowska
Adriana Polańska
Ryszard Żaba
Aleksandra Dańczak-Pazdrowska
author_sort Paweł Głuszak
collection DOAJ
description Pyoderma gangrenosum is a rare but highly debilitating dermatologic condition frequently associated with systemic disorders such as inflammatory bowel disease and rheumatoid arthritis. The clinical management of pyoderma gangrenosum is particularly challenging due to the absence of standardized diagnostic criteria and evidence-based treatment protocols, which complicates therapeutic decision-making. Dapsone, an anti-inflammatory and immunomodulatory agent, has demonstrated potential therapeutic efficacy in pyoderma gangrenosum by modulating neutrophilic activity, a key factor in the pathogenesis of this disease. This review endeavours to provide a comprehensive synthesis of clinical evidence regarding the application of dapsone in pyoderma gangrenosum management, particularly in scenarios where first-line therapies, such as glucocorticosteroids or biological agents, are contraindicated or inaccessible. Moreover, the review offers practical insights for the integration of dapsone into clinical practice.
format Article
id doaj-art-b8ade23900c54b15b20b44ce24d95ce2
institution DOAJ
issn 0033-2526
2084-9893
language English
publishDate 2025-02-01
publisher Termedia Publishing House
record_format Article
series Przegląd Dermatologiczny
spelling doaj-art-b8ade23900c54b15b20b44ce24d95ce22025-08-20T02:58:37ZengTermedia Publishing HousePrzegląd Dermatologiczny0033-25262084-98932025-02-01111534735710.5114/dr.2024.14857455784Dapson in the Treatment of Pyoderma Gangrenosum: a Narrative ReviewPaweł GłuszakJacek BeutlerNina KurkowskaAdriana PolańskaRyszard ŻabaAleksandra Dańczak-PazdrowskaPyoderma gangrenosum is a rare but highly debilitating dermatologic condition frequently associated with systemic disorders such as inflammatory bowel disease and rheumatoid arthritis. The clinical management of pyoderma gangrenosum is particularly challenging due to the absence of standardized diagnostic criteria and evidence-based treatment protocols, which complicates therapeutic decision-making. Dapsone, an anti-inflammatory and immunomodulatory agent, has demonstrated potential therapeutic efficacy in pyoderma gangrenosum by modulating neutrophilic activity, a key factor in the pathogenesis of this disease. This review endeavours to provide a comprehensive synthesis of clinical evidence regarding the application of dapsone in pyoderma gangrenosum management, particularly in scenarios where first-line therapies, such as glucocorticosteroids or biological agents, are contraindicated or inaccessible. Moreover, the review offers practical insights for the integration of dapsone into clinical practice.https://www.termedia.pl/Dapson-in-the-Treatment-of-Pyoderma-Gangrenosum-a-Narrative-Review,56,55784,1,1.htmldapsone pyoderma gangrenosum sulphone neutrophilic dermatosis
spellingShingle Paweł Głuszak
Jacek Beutler
Nina Kurkowska
Adriana Polańska
Ryszard Żaba
Aleksandra Dańczak-Pazdrowska
Dapson in the Treatment of Pyoderma Gangrenosum: a Narrative Review
Przegląd Dermatologiczny
dapsone
pyoderma gangrenosum
sulphone
neutrophilic dermatosis
title Dapson in the Treatment of Pyoderma Gangrenosum: a Narrative Review
title_full Dapson in the Treatment of Pyoderma Gangrenosum: a Narrative Review
title_fullStr Dapson in the Treatment of Pyoderma Gangrenosum: a Narrative Review
title_full_unstemmed Dapson in the Treatment of Pyoderma Gangrenosum: a Narrative Review
title_short Dapson in the Treatment of Pyoderma Gangrenosum: a Narrative Review
title_sort dapson in the treatment of pyoderma gangrenosum a narrative review
topic dapsone
pyoderma gangrenosum
sulphone
neutrophilic dermatosis
url https://www.termedia.pl/Dapson-in-the-Treatment-of-Pyoderma-Gangrenosum-a-Narrative-Review,56,55784,1,1.html
work_keys_str_mv AT pawełgłuszak dapsoninthetreatmentofpyodermagangrenosumanarrativereview
AT jacekbeutler dapsoninthetreatmentofpyodermagangrenosumanarrativereview
AT ninakurkowska dapsoninthetreatmentofpyodermagangrenosumanarrativereview
AT adrianapolanska dapsoninthetreatmentofpyodermagangrenosumanarrativereview
AT ryszardzaba dapsoninthetreatmentofpyodermagangrenosumanarrativereview
AT aleksandradanczakpazdrowska dapsoninthetreatmentofpyodermagangrenosumanarrativereview